Abstract
The immune system is unusual in two respects. It produces billions of new cells daily that traffic throughout the body and cells within the system proliferate rapidly following exposure to an infectious agent. Both of these attributes require that cell production be regulated by cell death. Human diseases characterized by accelerated cell death leading to immunodeficiency disorders or by reduced cell death leading to systemic autoimmune diseases have been identified. In certain autoimmune diseases, the immune system directs its powerful cytotoxic effector mechanisms against specialized cells such as oligodendrocytes in multiple sclerosis, the β cells of the pancreas in diabetes mellitus and thyrocytes in Hashimoto's thyroiditis. In this review, we examine the cytotoxic effector pathways implicated in cell death in organ specific autoimmune disorders.
Similar content being viewed by others
Article PDF
Author information
Authors and Affiliations
Corresponding author
Additional information
Edited by M. Piacentini
Rights and permissions
About this article
Cite this article
Ohsako, S., Elkon, K. Apoptosis in the effector phase of autoimmune diabetes, multiple sclerosis and thyroiditis. Cell Death Differ 6, 13–21 (1999). https://doi.org/10.1038/sj.cdd.4400459
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.cdd.4400459
Keywords
This article is cited by
-
Antiapoptotic fusion protein delivery systems
Macromolecular Research (2008)
-
Accumulation of the pro-apoptotic factor Bak is controlled by antagonist factor Mcl-1 availability
Apoptosis (2006)
-
An extended association screen in multiple sclerosis using 202 microsatellite markers targeting apoptosis-related genes does not reveal new predisposing factors
Journal of Negative Results in BioMedicine (2005)
-
Inflammatory cytokine regulation of TRAIL-mediated apoptosis in thyroid epithelial cells
Cell Death & Differentiation (2002)